🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Convulsion, Non-Epileptic

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain NCT06716801n/a1 site📍 Paris Aziende Chimiche Riunite Angelini Francesco S.p.A · Tests: Cenobamate Retraining and Control Therapy (ReACT) R33 Phase NCT06007053NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: ReACT, Supportive Therapy A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures NCT05819268NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: ReACT, CATCH-IT Modulating Movement Intention Via Cortical Stimulation NCT03233399NA1 site📍 New York NYU Langone Health · Tests: Sham TMS3 stimulation, rTMS of left or right angular gyrus (AG) or frontal cortex (FC), Anodal tDCS of left or right AG… Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical Trial NCT07747324Phase 1, Phase 21 site📍 Ribeirão Preto University of Sao Paulo · Tests: Ayahuasca Volatile Non-Invasive Biomarkers of Epileptic Seizures NCT05725174n/a2 sites📍 London📍 London University College London Hospitals · Tests: Sample Collection Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND NCT06362161n/a1 site📍 Birmingham University of Alabama at Birmingham Retraining and Control Therapy (ReACT)- Adults NCT06570954NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: ReACT Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy NCT07680842NA1 site📍 San Francisco University of California, San Francisco · Tests: Target optimization using LIFU, Serial LIFU stimulation Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES NCT05096273NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: ReACT AI-Based Mobile Intervention on Medication Non-Adherence and Transition NCT07445074NA2 sites📍 Orlando📍 Orlando University of Central Florida · Tests: Medilepsy® Chatbot AI-Enhanced, Medilepsy® Chatbot Standard Seizure Prediction Using Wearable EEG NCT06978842n/a2 sites📍 Haifa📍 Ramat Gan Dux Healthcare Inc. · Tests: Wearable EEG headband for passive brain signal acquisition
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy